Literature DB >> 7523132

Transurethral microwave thermotherapy versus transurethral catheter therapy for benign prostatic hyperplasia.

D Mulvin1, T Creagh, D Kelly, J Smith, D Quinlan, J Fitzpatrick.   

Abstract

Transurethral microwave thermotherapy (TUMT) is a single outpatient treatment for benign prostatic hyperplasia. It produces good symptomatic relief but minimal objective improvement in mean flow rates. We wished to evaluate the placebo effect of the transurethral catheter. We evaluated 40 patients with outflow obstruction, 20 had TUMT for 1 h and 20 had a catheter placed in the urethra without treatment for 1 h. Urinary flow rates improved in both groups (12.8-14.6 with TUMT, 10.0-12.4 with catheter). Significant reduction from pretreatment values occurred in symptom scores and postvoid residual urine volume in both groups following treatment. The subjective results of TUMT and the placebo effect seen in the catheter group cast doubt on our understanding of the mechanism of action of TUMT.

Entities:  

Mesh:

Year:  1994        PMID: 7523132     DOI: 10.1159/000475334

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Minimally invasive procedures and medical management-their relative merits in treating lower urinary tract symptoms of benign prostatic hyperplasia.

Authors:  B Djavan; M Marberger
Journal:  Rev Urol       Date:  2000

Review 2.  A clinical view of pressure-flow studies.

Authors:  J Nordling
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 3.  Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.

Authors:  Juan Va Franco; Jae Hung Jung; Mari Imamura; Michael Borofsky; Muhammad Imran Omar; Camila Micaela Escobar Liquitay; Shamar Young; Jafar Golzarian; Areti Angeliki Veroniki; Luis Garegnani; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-07-15

4.  Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Juan Va Franco; Luis Garegnani; Camila Micaela Escobar Liquitay; Michael Borofsky; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.